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Abstract: The article overviewed contemporary neuromodulation approaches and challenges. The importance of the 
neurostimulation techniques was justified. The SYMPATHOCOR-01 neuro-electrostimulation device 
characterization was presented. The case study of the neuro-electrostimulation mechanisms by means of the 
neuroimaging was described. Case study consisted of 3 phases: imaging prior to the neuro-
electrostimulation procedure, imaging right after the neuro-electrostimulation procedure and imaging after a 
5-day stimulation course. Results of the functional magnetic resonance imaging revealed improvement of 
the functional connectivity strength in several brain regions as well as normalization of default mode 
network activity. 
1 INTRODUCTION 
The relevance of new efficient methods 
development for the central nervous system (CNS) 
organic damages treatment is defined by the spread 
of these diseases, aging of population, growth of 
stress and technogenic factors (Zuliani et al. 2012). 
To some extent, a barrier in the development is lack 
of knowledge about the pathophysiological models 
of the functional disorders in the human brain. It 
justifies the necessity of contemporary methods 
attraction for the investigation.  
One of the most rapidly developing directions in 
this sphere is the neuromodulation (Thin et al. 
2013). However, the contemporary developments of 
the neuro-electrostimulators, applied in the medical 
practice, faces the high complexity of the nervous 
system organization, including powerful 








At the moment, basic approach for the treatment of 
central and peripheral nervous systems’ disorders is 
the so-called neuroprotective therapy (Stocchi and 
Olanow 2013). On the one hand, it improves 
normalization and enhance physiological activity of 
the neural tissue. On the other hand, it leads to 
recovery of structural damage, caused by various 
pathogenic effects, including traumatic, infectious-
inflammatory, vascular, and degenerative effects.  
2.1 Physiological Mechanisms of the 
Neural Adaptation 
Generally, damage of the nervous systems, involves 
whole complex of chains in the pathological process. 
Clinically, it leads to numerous neurological, mental, 
autonomic and regulatory disorders. Often it requires 
application of not a single ‘universal’ drug, but a 
complex therapy of the different medicines. 
The situation becomes unfavorable, as 
simultaneous usage of many drugs, accumulates not 
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only treatment effects, but also the side effects, 
which results from polypharmacy. In case of 
polypharmacy, the side effects suppress therapeutic 
effects, and the treatment becomes ineffective and 
dangerous (Maher et al. 2014). 
Described situation is especially unfavorable in 
cases when treatment interferes with the natural 
regulatory and adaptive process of the CNS, 
essentially acting as the stress-factor. In this case, 
stress adaptation systems take up work. These 
systems represent sophisticated regulatory complex, 
which is crucial for the activation and coordination 
of all changes in the organisms as response to the 
stress.  
Through both, self-regulation process and 
external regulation the stress system is implemented. 
The self-regulation of the stress system is based on 
feedback principles: adrenocorticotropic hormone 
(ACTH), cortisol and brain structures are 
fundamental (Jovanovic et al. 2010). Mechanisms of 
the external regulation are implemented by the 
stress-limiting system, which constrains stress 
system activity and excessive stress-reaction on 
central and periphery scale. Сentral scale includes 
GABAergic, opioidergic and serotoninergic systems; 
whereas the periphery scale includes adenosine, 
prostaglandins and antioxidant system, as well as the 
NO generation system (Stahl and Wise 2008). 
Moreover, the endogenic neuropeptids, like 
substance P, Brain-derived neurotrophic factor 
(BDNF) and others, are also important for the stress 
reaction regulation. (Dupont et al. 1981, Rothman et 
al. 2012). At the same time, complex neurohumoral 
mechanisms of the stress-realizing and stress-
limiting interaction, organize multiphasic adaptation 
reaction of the organism (Holaday 1983, Knapman 
et al. 2012).  
Furthermore, in case of a stress, caused by the 
disease, by the direct and side-effects of the drugs, 
complicated mechanisms of immune system 
disorders are implemented. Immune system disorder 
may result in the secondary immunodeficiency state 
of the neurogenic origin (Turnbull and Rivier 1999, 
Kronfol and Remick 2000, Davis et al. 2008).  
If one improves the adaptive possibilities of 
autonomic regulation, then central regulation 
mechanisms come to help. Central regulation 
mechanisms include direct control of endocrine, 
immune, cardiovascular and digestive systems, by 
means of the comprehensive communication 
networks of neurohumoral interaction, hormones, 
neuromediators and immunotoxic agents (Dedovic et 
al. 2009). 
 
2.2 Therapeutic Techniques  
There is a tendency to assume, that the basis of the 
neuro-protective therapy are numerous medicines, 
which have wide range of action mechanisms and 
pharmacokinetic properties. Different medicines 
affect on range of the pathogenetic components of 
the particular pathologic process (Greenberg et al. 
2009). 
However, the pharmacological approach is 
effective only among the one third of the patients. In 
most cases, the life-long drug regimen is implied, 
which is accompanied by the quantity side effects. 
Essentially, the pharmacological approach is just a 
substitution therapy and does not treat the disorder 
itself (Stahl and Moore 2013). 
2.3 Neuro-electrostimulation 
Techniques 
During recent years, a number of investigations have 
intensified for the universal and less harmful 
neuroprotection techniques. Such techniques were 
labeled as neurostimulation (Charleston et al. 2010). 
To the date numerous data on specific 
neurostimulation techniques application have been 
accumulated. A number of such key features can 
classify such techniques: 
• exposure area – brain, spinal cord, periphery 
nerves; 
• invasive and non-invasive techniques; 
• physiological properties of stimulated neural 
structures - afferent and efferent stimulation; 
• mechanism of the stimulation – internal and 
external stimulation; 
• the size of stimulated neural tissues – local 
and general stimulation; 
• physical nature of the stimulating factor – 
magnetic, electric, ultrasound, optic 
stimulation. 
One can obtain different clinical effects of the 
neurostimulation depending on the stimulated 
department of the nervous system. In either case, the 
nervous system performs the integral function and 
provide interconnected regulation of whole organism 
systems activities. It means that neurostimulation 
effects are not limited by the nervous system itself, 
but also can influence the variety of processes in the 
organism as a whole. 
Contrary to the complex medicines therapy, 
proper application of the physical neurostimulation 
does not cause additional stress reactions of the 
organism, as it does not actively interfere in 
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regulatory, biochemical and immune process of the 
organism. This fact allows widely applying 
neurostimulation techniques for the medical 
rehabilitation in many pathological cases.  
It is of great interest to find new targets and 
technical means of neurostimulation, based on the 
anatomical knowledge and knowledge of the 
nervous system physiology, for the particular 
medical tasks. 
2.4 SYMPATHOCOR-01 Device 
The SYMPATHOCOR-01 device implements the 
technology of multi-channel neuro-
electrostimulation. Spatially distributed physical 
field is formed: its features are in accordance with 
endogenic process in the neural structures. This 
technology allows managing activity of the 
conducting formations and performs the 
neuromodulation process. The medical application 
of the SYMPATHOCOR-01 device is implemented 
as the DCASNS technique - Dynamic Correction of 
the Sympathetic Nervous System Activity. The 
DCASNS technique provides correction of 
autonomic balance, defined by the relation between 
the activities of the parasympathetic and sympathetic 
departments of the autonomic nervous system 
(ANS) (Kublanov, Shmirev, et al. 2010).  
At present, the SYMPATHOCOR-01 device is 
applied in the clinical practice to correct and control 
the following pathologies: migraine, 
neurocirculatory dystonia, traumatic brain injury and 
brain concussion, alcohol and narcotic abstinences, 
hypertonic diseases, obliterate atherosclerosis of the 
lower limbs, Raynaud’s disease, trigeminal nerve 
inflammation, sensorineural deafness, degenerative 
diseases of vision and atrophy of the optical nerve, 
osteochondrosis of the back bone, neuropathies of 
various genesis, cephalalgia syndrome, 
hyperhidrosis syndrome, syndrome of the orthostatic 
hyposthenia and postural tachycardia, vestibular 
disease, vegetative deregulation syndrome, epilepsy  
(Kublanov et al. 2017). 
The design process of the SYMPATHOCOR-01 
device medical application was accomponied by the 
experimental studies on laboratory animals by 
modelling the chronical pathological (muscle 
ischemia) and the actute (immobilising stress) states 
(Kublanov, Danilova, et al. 2010, Kublanov et al. 
2012).  
For pathological state, in the previous works was 
noted that on organs and tissue level the blood 
supply recovery is associated with increase in the 
number of the capillaries. On the cross-section of the 
muscle, after the neuro-electrostimulation 
application, the swelling, which is characteristic for 
the ischemia case, was also decreased. Moreover, 
the visually noted recovery of the transverse 
striation, define the regeneration of the muscle 
tissues. On the cellular level, the decrease of the 
permeability of the damaged membranes is noted. 
On the molecular level, the endogenic toxins number 
was reduced.  
For the acute state, after a single procedure of 
the neuro-electrostimulation, the motion activity had 
a tendency towards the normalization. On the cell 
level, the increased membranes permeability of the 
cells and muscle fibers did not worsen. On the 
organism level, the behavior reaction changed: the 
adaptation to the immobilized stress was improved 
and the animal became less aggressive. 
The single-photon emission computed 
tomography images have shown that the neuro-
electrostimulation by the ‘SYMPATHOCOR-01’ 
device allows to change neurogenic regulation of the 
vascular tone, to improve neurometabolism in the 
brain, to suppress epileptic activity, stimulating 
neurotransmission, to recover intracerebral 
connections (Kublanov et al. 2004). 
Emergence of the modern neurovisualization 
methods opens the possibilities in the neuroplasticity 
investigation. In particular, functional magnetic 
resonance imaging (fMRI), which is an intravital 
non-invasive dynamic investigation of active brain 
structures during their functioning. The fMRI 
method is based on different properties of 
oxyhemoglobin, carrier of O2, and 
deoxyhemoglobin, a product formed in the brain 
parenchyma in magnetic field. This proportion is 
reflected by the BOLD-phenomenon (blood 
oxygenation level independent), a marker of 
neuronal activity. Stereotyped or, on the contrary, 
heuristic actions as well as sensorimotor, visual-
auditory, and speech operations are associated with 
the formation and/or reorganization of preexisting 
neuronal ensembles (NE) in the brain. Their activity, 
being spontaneous or produced by the environment, 
appears as an increase of local blood filling of the 
brain tissue and in modulation of the mechanisms of 
blood flow rate and volume regulation in the brain 
(Savostyanov et al. 2016).  
The goal of the current pilot study is to 
investigate the influence of the SYMPATHOCOR-
01 stimulation by means of the functional 
neurovisualisation. 
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3 CLINICAL CASE STUDY 
In the December of 2016, at the State Scientific-
Research Institute of Physiology & Basic Medicine, 
the pilot study of the hemodynamic reactions, 
caused by the neuronal activity of the brain, by 
means of the fMRI, was conducted.  
Single male patient K., age 25, diagnosed with 
ICD T90.5 (Sequelae of intracranial injury), has 
participated in the pilot study. The patient K. has 
signed the informative participation consent. The 
study was carried out on the MR system GE 
Discovery MR750W, 3.0 Tesla, in accordance with 
the following protocols: 
1) T1 SPGR 3D reconstruction, up to 256 cross-
sections, voxel size 1 mm3; mandatory 
capturing the whole head surface, including 
nose and ears; 
2) fMRI in the resting state mode, and in visual 
stimuli presentation mode (33 cross-sections, 
thickness up to 4,5 mm) 
3) tractography (diffusion tensor imaging - DTI, 
72 cross-sections, 2 mm each; 64 directions) 
4) T2-WI, FLAIR (weighted images for 
exclusion of the chronic gliosis sources). The 
stimuli were send by means of the Nordic 
NeuroLab BrainEx. 
For registration to standard space a T1 high-
resolution 3D MPRAGE (magnetization prepared 
rapid gradient echo) was performed. with the 
following scan parameters: repetition time (TR) = 2.5 
s, echo time (TE) = 3.52 ms, 190 sagittal slices with 
no gap, field-of-view (FoV) = 230 mm, flip angle 
(FA) = 8°, in-plane resolution = 1.2×1.2 mm2, slice 
thickness = 1.2 mm. During RS-fMRI acquisition, 
using gradient echo T2* weighted EPI, participant 
was instructed to keep the eyes closed and not to 
think about anything. The imaging parameters were: 
100 volumes, TR = 3 s, TE = 52 ms, FA = 90°, 28 
interleaved slices, slice thickness = 5 mm, imaging 
matrix 64×64 and FoV = 220 mm.  
The study timeline is presented in the table 1.  
Table 1: Study timeline. 

















T1-sag – weighted image in the sagittal projection; 
RS - resting state functional MRI (BOLD signal); 
Visual Nordic – functional MRI in the visual stimuli 
paradigm (activation of the visual cortical areas); 
MRA - MR-angiography, a medical test that helps 
physicians diagnose and treat medical conditions 
and diseases of the blood vessels. 
The first phase was conducted for the baseline 
state evaluation. The second phase was conducted 
immediately after the neuro-electostimulation 
procedure in order to evaluate short-term reaction of 
the CNS. The third phase was conducted 3 days after 
5 procedures of the DCASNS in order to evaluate 
long term reaction of the CNS. The biotropic field 
features of the SYMPATHOCOR-01 were set in 
accordance with the DCASNS technique. There 
were two 30-minutes procedure every day.  
Data were analysed using Matlab (SPM12, 
CONN14). For a ROI-based analysis, Medial 
Prefrontal Cortex was chosen as a seed ROI, as it is 
considered a part of default mode network (DMN).  
4 RESULTS 
The one-sample t-test showed spatial pattern of 
activation (connectivity) and deactivation in DMN. 
In I and II phases along decreased functional 
connectivity in DMN, following changes were 
identified:  
• increased negative functional connectivity 
strength (FCs) with Anterior and Dorsolateral 
Prefrontal Cortex (BA9, BA46), 
• decreased positive FCs with Ventral 
Posterior Cingulate Cortex (BA31), Premotor 
(BA6) and Somatosensory Cortex (BA7).  
In phase III positive FCs with Angular Gyrus 
(BA39), Dorsal Posterior Cingulate Cortex (BA 31), 
Dorsal Frontal Cortex (BA8), Associative Visual 
Cortex (BA19), Orbitofrontal Cortex (BA11), 
Inferior Prefrontal Gyrus (BA47) appeared stronger. 
Although less areas of deactivation were present. 
Besides, the whole DMN activity showed symmetry. 
In phase II a slight increase in overall activation 
strength was noted. 
The participant suffered periodic headaches of a 
pressing nature without a clear localization, 
provoked by increased physical and emotional 
stress, as well as excessive sleep, and episodic 
tension headaches. With that in mind, we can 
outline, that, regarding DMN activity, stress induced 
functional connectivity alterations took place 
initially in the medial prefrontal cortex, medial 
orbitofrontal cortex, posterior cingulate cortex and 
some other regions. The follow-up examination 
showed definite normalization of DMN activity. 




Figure 1: I phase – prior to the treatment. 
 
Figure 2: II phase – after a single DCASNS procedure. 
 
Figure 3: III phase – after 5 DCASNS procedures. 
5 CONCLUSIONS 
Results of the SYMPATHOCOR-01 neuro-
electrostimulation effects by means of the functional 
neuroimaging allowed revealing areas of the most 
active changes in the brain tissues. One can claim 
that effect of the SYMPATHOCOR-01 device is 
spreading from the neck area through the afferent 
conducting paths up to the cortical formations of the 
brain. 
Obtained in the pilot study data allows to 
consider the fMRI technology as the promising tool 
for the neuro-electrostimulation mechanisms 
investigation. The data could also form new 
treatment techniques of the non-invasive multi-
electrode neck neural structures electrosimulation 
application for treatment of the psychiatric and 
neurological disorders. Namely, disorders 
accompanied by the neurodeheneration (Alzheimer 
disease, Parkinson disease, dementias); 
consequences of the brain traumas, neurotoxications, 
depressive and anxiety disorders, strokes. 
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